Publication | Closed Access
Phase II Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Sorafenib in Japanese Patients with Advanced Renal Cell Carcinoma
151
Citations
16
References
2007
Year
Sorafenib showed encouraging efficacy and was well tolerated in Japanese patients with metastatic RCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1